Sleep promoting role of melatonin receptor agonists

Sleep

Volumn 28, Issue 3, 2005, Pages 300-301

  Zee, Phyllis C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; MELATONIN 1 RECEPTOR; MELATONIN 1 RECEPTOR AGONIST; MELATONIN 2 RECEPTOR; MELATONIN 2 RECEPTOR AGONIST; MELATONIN RECEPTOR; MELATONIN RECEPTOR AGONIST; RAMELTEON; UNCLASSIFIED DRUG;

CIRCADIAN RHYTHM; CORE TEMPERATURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EDITORIAL; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; INSOMNIA; LATENT PERIOD; MEMBRANE BINDING; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR BINDING; SLEEP PATTERN; SLEEP TIME; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; TIME;

CIRCADIAN RHYTHM; HUMANS; MELATONIN; RECEPTORS, MELATONIN; SLEEP;

EID: 14644437798     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. Dijk DJ and Lockley SW, Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol, 2002. 92(2): 852-62.
2. Dijk DJ, et al., Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J Physiol, 1999. 516 (Pt 2): 611-27.
3. Wurts SW and Edgar DM, Circadian and homeostatic control of rapid eye movement (REM) sleep: promotion of REM tendency by the suprachiasmatic nucleus. J Neurosci, 2000. 20(11): 4300-10.
4. Zhdanova IV, et al., Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther, 1995. 57(5): 552-8.
5. Stone BM, et al., Hypnotic activity of melatonin. Sleep, 2000. 23(5): 663-9.
6. Lewy AJ, et al., Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int, 1992. 9(5): 380-92.
7. Rogers NL, et al., Potential action of melatonin in insomnia. Sleep, 2003. 26(8): 1058-9.
8. Dollins AB, et al., Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A, 1994. 91(5): 1824-8.
9. Hughes RJ and Badia P, Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep, 1997. 20(2): 124-31.
10. Dijk DJ and Cajochen C, Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J Biol Rhythms, 1997. 12(6): 627-35.
11. Krauchi K and Wirz-Justice A, Circadian clues to sleep onset mechanisms. Neuropsychopharmacology, 2001. 25(5 Suppl): S92-6.
12. Lavie P, Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms, 1997. 12(6): 657-65.
13. Shochat T, Haimov I, and Lavie P, Melatonin-the key to the gate of sleep. Ann Med, 1998. 30(1): 109-14.
14. Reppert SM, Weaver DR, and Ebisawa T, Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 1994. 13(5): 1177-85.
15. Nosjean O, et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem, 2000. 275(40): 31311-7.
16. Witt-Enderby PA, et al., Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci, 2003. 727(20): 2183-98.
17. von Gall C, Stehle JH, and Weaver DR, Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res, 2002. 309(1): 151-62.
18. Dubocovich ML, Benloucif S, and Masana MI, Melatonin receptors in the mammalian suprachiasmatic nucleus. Behav Brain Res, 1996. 73(1-2): 141-7.
19. Reppert SM, Weaver DR, and Godson C, Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci, 1996. 17(3): 100-2.
20. Liu C, et al., Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron, 1997. 19(1): 91-102.
21. Mason R and Brooks A, The electrophysiological effects of melatonin and a putative melatonin antagonist (N-acetyltryptamine) on rat suprachiasmatic neurones in vitro. Neurosci Lett, 1988. 95(1-3): 296-301.
22. Shibata S, Cassone VM, and Moore RY, Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro. Neurosci Lett, 1989. 97(1-2): 140-4.
23. Hunt AE, et al., Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol, 2001. 280(1): C110-8.
24. Jin X, et al., Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol, 2003. 23(3): 1054-60.
25. Cajochen C, Krauchi K, and Wirz-Justice A, Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol, 2003. 15(4): 432-7.
26. Pintor J, et al., Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol, 2001. 416(3): 251-4.
27. Lotufo CM, et al., Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol, 2001. 430(2-3): 351-7.
28. Mintzer MZ, et al., Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behav Pharmacol, 1997. 8(6-7): 561-74.
29. Yous SJ, et al., Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem, 1992. 35(8): 1484-6.
30. Uchikawa O, et al., Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. J Med Chem, 2002. 45(19): 4222-39.